Healthcare: 3 Tough Luck Tumbles – Are They Buys?

Industry Focus - En podcast af The Motley Fool

Prøv Podimo gratis! i 30 dage

Et univers fyldt med hundredvis af eksklusive podcasts & lydbøger, klik her for at prøve

Kategorier:

Spark Therapeutics, Rite Aid, and Alnylam shares have tumbled following news, but that doesn’t necessarily make all three stocks worth buying. Stocks: ONCE, RAD, ALNY

Visit the podcast's native language site